科研之友
微信
新浪微博
Facebook
分享链接
摘要
Objective: Several investigations have been conducted regarding the interaction between Apolipoprotein A2 (APOA2) 265 T > C polymorphism and dietary intake of saturated fatty acids (SFAs) on obesity in healthy individuals or type 2 diabetes mellitus (T2 DM) patients. The aim of the present study is to examine the effect of this interaction on inflammatory markers in T2 DM patients. Methods: This is a comparative cross-sectional study on 180 T2 DM patients with known APOA2 genotype. Dietary intake was assessed by food-frequency questionnaire and serum levels of inflammatory markers (interleukin [IL]-18, pentraxin 3, and high -sensitivity C-reactive protein [hs-CRP] were measured. The subjects were dichotomized into "high" and "low" categories, based on the median dietary intake of polyunsaturated fatty acids (PUFAs), monounsaturated fatty acids (MUFAs), and SFAs. The data were analyzed by analysis of covariance multivariate interaction model. Results: In CC genotype, higher median intake of PUFAs and MUFAs was associated with decreased serum levels of IL -18 and hs-CRP (P = 0.014 and 0.008, respectively). In T-allele carriers, higher median intake of SFAs was associated with increased serum hs-CRP level (P < 0.001). There was a significant relationship between APOA2 polymorphism and PUFA intake on serum IL -18 level (P interaction = 0.03). Moreover, the relationship between this polymorphism and SFA and MUFA intake on serum hs-CRP level was statistically significant (P interaction = 0.03 and 0.024, respectively). Conclusions: In T2 DM patients, the dietary intake of antiinflammatory fatty acids, such as w-3 PUFAs and MUFAs, could reduce the inflammatory effects associated with the CC genotype. In addition, proinflammatory fatty acids, such as SFAS, could overcome the antiinflammatory effect of the T-allele. Further studies are needed to confirm these findings.
- 出版日期2017-5
